Body Central Corp. (BODY) Posts Q1 Loss of 59c/Share

Body Central Corp. (NASDAQ: BODY) reported Q1 EPS of ($0.56), $0.20 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $59.7 million versus the consensus estimate of $62.96 million.

Brian Woolf, Body Central's CEO, stated: "Our first quarter results were consistent with the discussion on our March 25, 2014 year-end conference call. We saw positive comp sales in bottoms and lingerie, along with improving trends in shoes. This performance was however overshadowed by the continued challenges in tops and dresses. Our direct business continues to transition from a historical catalog driven business, to an e-commerce driven business. While the e-commerce sales continue to grow, the catalog side has become unprofitable and less relevant to our customer. As a result, we will continue to evaluate the merits of our catalog business for the balance of the year."

Mr. Woolf further stated: "We continue to monitor inventory levels closely while refining assortments and messaging that can stimulate traffic and sales. We remain focused that taking these steps will improve the customer experience in both our stores and e-commerce businesses, and ultimately improve our financial performance."

For earnings history and earnings-related data on Body Central Corp. (BODY) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Workhorse Group (WKHS) Misses Q2 EPS by 77c
• Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c